This is the authors' abstract. We don't add key points for this paper.
The use of SGLT2i and GLP-1RA appears to be effective and safe in diabetic KTRs with good outcomes. Randomized control trials are required to confirm these findings and establish guidelines.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mahmoud et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: